Pete Stibbs: Launching New VTE Management Webinar Series at Argon Medical
Pete Stibbs, Senior Vice President, Global Medical Affairs and Medical Director at Argon Medical Devices, shared Argon Medical Devices’s post on LinkedIn:
“I’m excited to share the launch of our new VTE Management Webinar Series at Argon Medical.
Continuous education is essential as the evidence surrounding venous thromboembolism continues to evolve.
From updated clinical guidelines and landmark trials to advances in mechanical thrombectomy and patient selection, our goal is to provide practical, evidence-based discussions that clinicians can apply directly to patient care.
I’m especially pleased that our inaugural session will feature Professor Stephen Black, whose expertise and contributions to venous disease have helped shape the field.
If you’re involved in the management of DVT, PE, or other venous disorders, I hope you’ll join us for what promises to be an outstanding discussion.
I look forward to seeing many colleagues, collaborators, and friends there.”
Argon Medical Devices shared a post on LinkedIn:
“VTE Treatment Is Evolving. Are You Keeping Up?
Join Professor Stephen Black and Argon Medical for the first episode of our new VTE Management Webinar Series: Next-Generation VTE Care – a comprehensive discussion on updated guidelines, intervention strategies, and clinical impact.
Together, we’ll explore:
- How evolving guidelines and landmark trial data are redefining VTE intervention
- Why early intervention matters for long-term outcomes and quality of life
- The technologies and evidence shaping the next generation of VTE treatment
- The value of mechanical thrombectomy in an increasingly outcomes and cost-focused healthcare environment
August 19 | 5:00 PM EDT (10:00 PM BST)
We hope you’ll join us for this conversation – register now to save your seat for Episode One of a series you won’t want to miss.
Click here to register.”
Stay updated with Hemostasis Today.
-
Sep 26, 2026, 16:04Isabelle Feldhaus: What the New ASH Iron Deficiency Guidance Means for Care
-
Sep 26, 2026, 15:55Francesca Palandri: The R-NAT Score Developed in Ruxolitinib-Treated MF Patients
-
Sep 26, 2026, 15:49Alex Ehsan: Antiphospholipid Syndrome A Practical Guide
-
Sep 26, 2026, 15:42Michael Tadao Inouye: The Next Frontier in Genomic Population Health
-
Sep 26, 2026, 15:32Katariina Öörni: Familial Hypercholesterolaemia in Children Why Early Diagnosis Matters
-
Sep 26, 2026, 15:30P-Selectin as a Therapeutic Target in Thrombosis
-
Sep 26, 2026, 15:27Berkan Kurt: The Role of Biomarkers in Cardiovascular Prevention
-
Sep 26, 2026, 15:21Consuela A. Albright: Five Concrete Ways Steps to Advocate for Sickle Cell Disease
-
Sep 26, 2026, 15:09New ASH Funding Opportunities for Hematology Researchers